Eliahu Golomb

Summary

Affiliation: Shaare Zedek Medical Center
Country: Israel

Publications

  1. ncbi request reprint Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family
    Eliahu Golomb
    Laboratory of Molecular Cardiology, NHLBI, National Institute of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 279:2800-8. 2004
  2. ncbi request reprint Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer
    Moshe Carmon
    Breast Health Center, Shaare Zedek Medical Center, Jerusalem, Israel
    Breast J 12:199-201. 2006
  3. ncbi request reprint The "Sentinel Chain": a new concept for prediction of axillary node status in breast cancer patients
    Moshe Carmon
    Department of Surgery, Shaare Zedek Medical Center, affiliated with the Faculty of Health Sciences, Ben Gurion University of the Negev, Jerusalem, Israel
    Breast Cancer Res Treat 97:323-8. 2006
  4. ncbi request reprint Induction of nonmuscle myosin heavy chain II-C by butyrate in RAW 264.7 mouse macrophages
    Denis B Buxton
    Laboratory of Molecular Cardiology, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 278:15449-55. 2003
  5. ncbi request reprint Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients
    Moshe Carmon
    Breast Health Center, Shaare Zedek Medical Center, Jerusalem, Israel
    Breast J 12:424-7. 2006

Detail Information

Publications5

  1. ncbi request reprint Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family
    Eliahu Golomb
    Laboratory of Molecular Cardiology, NHLBI, National Institute of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 279:2800-8. 2004
    ..5 + 7.2 microm. HMM II-C1 translocated actin filaments at a rate of 0.05 + 0.011 microm/s in the absence of tropomyosin and at 0.072 + 0.019 microm/s in the presence of tropomyosin in an in vitro motility assay...
  2. ncbi request reprint Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer
    Moshe Carmon
    Breast Health Center, Shaare Zedek Medical Center, Jerusalem, Israel
    Breast J 12:199-201. 2006
    ..A generous axillary incision and systematic palpation of the axilla reduces the false-negative rate and should be a part of the SLNB procedure...
  3. ncbi request reprint The "Sentinel Chain": a new concept for prediction of axillary node status in breast cancer patients
    Moshe Carmon
    Department of Surgery, Shaare Zedek Medical Center, affiliated with the Faculty of Health Sciences, Ben Gurion University of the Negev, Jerusalem, Israel
    Breast Cancer Res Treat 97:323-8. 2006
    ..The aim of this study was to identify a subgroup of patients with positive SLNs and negative NSNs, on the basis of tumor involvement patterns in multiple radioactive nodes...
  4. ncbi request reprint Induction of nonmuscle myosin heavy chain II-C by butyrate in RAW 264.7 mouse macrophages
    Denis B Buxton
    Laboratory of Molecular Cardiology, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 278:15449-55. 2003
    ..8-Bromo-cGMP had no effect on nonmuscle myosin heavy chain induction, consistent with a cGMP-independent mechanism for nitric oxide-mediated inhibition of nonmuscle myosin heavy chain II-C induction...
  5. ncbi request reprint Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients
    Moshe Carmon
    Breast Health Center, Shaare Zedek Medical Center, Jerusalem, Israel
    Breast J 12:424-7. 2006
    ..The number of hot spots in preoperative mapping should serve as a rough indicator of the smallest number of nodes the surgeon should attempt to resect, but not the exact number of nodes expected to be found...